Does TROFOSFAMIDE Cause Myelodysplastic syndrome? 18 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 18 reports of Myelodysplastic syndrome have been filed in association with TROFOSFAMIDE. This represents 16.5% of all adverse event reports for TROFOSFAMIDE.
18
Reports of Myelodysplastic syndrome with TROFOSFAMIDE
16.5%
of all TROFOSFAMIDE reports
9
Deaths
1
Hospitalizations
How Dangerous Is Myelodysplastic syndrome From TROFOSFAMIDE?
Of the 18 reports, 9 (50.0%) resulted in death, 1 (5.6%) required hospitalization.
Is Myelodysplastic syndrome Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TROFOSFAMIDE. However, 18 reports have been filed with the FAERS database.
What Other Side Effects Does TROFOSFAMIDE Cause?
Acute myeloid leukaemia (18)
Product use in unapproved indication (16)
Off label use (15)
Neutropenia (14)
Anaemia (13)
Dyspnoea (12)
Oedema (10)
Pleural effusion (10)
Hepatosplenomegaly (9)
Hyperleukocytosis (9)
What Other Drugs Cause Myelodysplastic syndrome?
CYCLOPHOSPHAMIDE (1,545)
LENALIDOMIDE (1,285)
DOXORUBICIN (1,236)
RITUXIMAB (1,054)
VINCRISTINE (966)
ETOPOSIDE (936)
DEXAMETHASONE (759)
METHOTREXATE (728)
CYTARABINE (715)
CARBOPLATIN (698)
Which TROFOSFAMIDE Alternatives Have Lower Myelodysplastic syndrome Risk?
TROFOSFAMIDE vs TROPATEPINE
TROFOSFAMIDE vs TROPICAMIDE
TROFOSFAMIDE vs TROSPIUM
TROFOSFAMIDE vs TROSPIUM\XANOMELINE
TROFOSFAMIDE vs TRUVADA